Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and colestipol

ezetimibe has been researched along with colestipol in 3 studies

Compound Research Comparison

Studies
(ezetimibe)		Trials
(ezetimibe)		Recent Studies (post-2010)
(ezetimibe)		Studies
(colestipol)		Trials
(colestipol)		Recent Studies (post-2010) (colestipol)
2,4845631,46539911016

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM1
Armani, A; Guyton, JR; Jacobson, TA; McKenney, JM1
Cai, T; Can, A; Castro, VM; Dligach, D; Du, R; Finan, S; Gainer, V; Murphy, S; Savova, G; Shadick, NA; Weiss, ST; Yu, S1

Other Studies

3 other study(ies) available for ezetimibe and colestipol

ArticleYear
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
    The American journal of cardiology, 2004, Sep-15, Volume: 94, Issue:6

    Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome

2004
Safety considerations with gastrointestinally active lipid-lowering drugs.
    The American journal of cardiology, 2007, Mar-19, Volume: 99, Issue:6A

    Topics: Anticholesteremic Agents; Azetidines; Clinical Trials as Topic; Colestipol; Confidence Intervals; Evidence-Based Medicine; Ezetimibe; Humans; Hypolipidemic Agents; Liver; Muscle, Skeletal

2007
Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture.
    Stroke, 2018, Volume: 49, Issue:5

    Topics: Adult; Aged; Aneurysm, Ruptured; Benzimidazoles; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Ezetimibe; Female; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Intracranial Aneurysm; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oligonucleotides; PCSK9 Inhibitors; Propensity Score; Protective Factors

2018